Safety and Systemic Consequences of Pleurodesis with Three Different Doses of Silver Nitrate in Patients with Malignant Pleural Effusion

Publisher： Karger

E-ISSN： 1423-0356|89|4|276-283

ISSN： 0025-7931

Source： Respiration, Vol.89, Iss.4, 2015-03, pp. : 276-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety Profile of the Use of Iodopovidone for Pleurodesis in Patients with Malignant Pleural Effusion

By  

Respiration, Vol. 90, Iss. 5, 2015-0 ,pp. : 369-375

Karger

Access to resources Recommend Favorite

Prognostic Factors in Patients with Malignant Pleural Effusion

By  

Respiration, Vol. 88, Iss. 2, 2014-06 ,pp. : 175-175

Karger

Access to resources Recommend Favorite

Best Current Therapy for Patients with Malignant Pleural Effusion

By  

Respiration, Vol. 85, Iss. 1, 2012-11 ,pp. : 13-14

Karger

Access to resources Recommend Favorite

Malignant Pleural Effusion: Prognostic Factors for Survival and Response to Chemical Pleurodesis in a Series of 120 Cases

By  

Respiration, Vol. 65, Iss. 2, 1998-04 ,pp. : 108-113

Karger

Access to resources Recommend Favorite

Chemical Pleurodesis for Malignant Pleural Effusion: How Far Have We Come in 80 Years?

By  

Respiration, Vol. 90, Iss. 5, 2015-0 ,pp. : 355-356

Karger

Access to resources Recommend Favorite